Lilly, NCATS team on 'Wikipedia' of drug development
This article was originally published in Scrip
Executive Summary
Like the nine lives of cats, drugs like Merck's Vioxx (rofecoxib) – declared dead in 2004 after being linked to serious adverse cardiovascular events – could potentially be revived if a collaboration between the US National Institutes of Health's (NIH) newly created National Center for Advancing Translational Sciences (NCATS) and Lilly is successful.